Sana Biotechnology Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Sana Biotechnology Inc trades at $3.68 (market cap $1.13B), while State Street Real Estate Select Sector SPDR ETF trades at $45.16. The key difference: State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | XLRE | |
|---|---|---|
Market Cap | $1.13B | — |
Sector | Health | Sector/Thematic |
52-Week High | $5.92 | $46.01 |
52-Week Low | $2.68 | $40.01 |
Enterprise Value | $1.05B | — |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →